1276 COVID-19 survivors were studied. The proportion of patients with at least one sequelae symptom decreased from 68% at 6 months to 49% at 12 months. The proportion of patients with dyspnoea slightly increased from 26% at 6-month visit to 30% at 12-month visit. Additionally, more patients had anxiety or depression at 12-month visit. Matched COVID-19 survivors at 12 months had more problems with mobility, pain or discomfort, and anxiety or depression, and had more prevalent symptoms than did controls.
